In this work, the synthesis of new N-tosyl aza-carbapterocarpane analogues with potential antiproliferative action in leukemia and breast cell lines was developed. The aza-carbapterocarpanes and spiro-isoindolines compounds were prepared using different synthetic approaches and classified in Group I and II respectively. The key step for obtaining group I compounds was the palladium catalyzed Heck-type azaarylation reaction from commercially synthesized substituted tetralones and substituted N-tosyl iodoanilines. Three compounds of this group were evaluated for their antiproliferative action in leukemia cell lines and breast cancer cells lines. The compound N-tosyl-aza-carbaptercarpene presented IC50 = 1,93 0,88 , 2,18 (plus or minus) 1,47 micrometers e 2.89 (plus or minus) 0,92 micrometers. On the other hand, the aza-carbapterocarpene compound was inactive in these same lines, suggesting the role of the absence of the arylsulfonamide group for the antileukemic activity does not occur .The group II, denominated spiroisoindolines, were synthesized by diastereoselective addition of organomagnesium to chiral N-tert-butane sulfinylimines, followed by a palladium catalyzed intramolecular Buchwald-Hartwig amination. The N-tert-butane sulfinylimines were obtained through commercial tetralones, chromanones and thiochromanones by the condensation reaction with commercial N-tert-butanesulfinamides in a solvent free sistem using titanium tetraethoxide. After nucleophilic addition reactions with organomagnesium, chiral auxiliary removal and intramolecular cyclization, the compounds were obtained enantiomerically pure and were evaluated in K562 and FESP leukemia lines. Although these compounds presented low potency compared to the tested lines (IC50 between 31.85 (plus or minus) 3.0 micrometers and 77.58 (plus or minus) 5.76 micrometers), it was observed that there of them present relevant differences between enantiomers as soon as collateral sensitivity, acting in leukemia multiresistent cell lines.